Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

REXULTI

A to Z: Drugs in Highlight: R is for REXULTI®

News A to Z Feature 03/04/2025

This series continues to explore the fascinating world of pharmaceuticals. Next up is R is for REXULTI® (from Otsuka Pharmaceutical), also sold under the brand name RXULTI®, It is an antipsychotic medicine used to treat schizophrenia in adults. It is also used as an adjunctive therapy for the treatment of major depressive disorder.

Read more
Brain With Cogs Jan 2022
Industry news 10/02/2023

An Update Regarding the DABUS Debate

Miriam Payne January 2023
Industry news, News 10/02/2023

She did it! Secerna-sponsored physics graduate completes solo Atlantic row with new race record

NCRABTREE - Secerna Headshots September 2024 127
Team news, Careers 22/12/2022

Niamh Crabtree in profile

Untitled Design 2023 02 10T100130.018
News, Team news 15/12/2022

Intrepid explorer sets off to “Seas the Day”

Secerna Christmas Mailer 2022 800X1160px (1)
Team news 15/12/2022

Festive Greetings from all at Secerna

Surgeon
European, Industry news 01/12/2022

New Developments in MedTech Patenting at the European Patent Office

Dermot Roche Press 800X800px Colour Temp Pic
European, Events, Team news 23/11/2022

Secerna to attend Knowledge Transfer Ireland Impact Awards

European Patent Office Building
European, Industry news 08/11/2022

How To Make Life Easier At The EPO – Exclusion of Diagnostic Methods

EPO 2021
European, Industry news 01/11/2022

Plausibility at the EPO - G2/21

16 17 18 19 20 21 22 23 24 25 26